These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10722616)

  • 21. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans.
    Collins HL; Bancroft GJ
    Eur J Immunol; 1992 Jun; 22(6):1447-54. PubMed ID: 1601035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma stimulates the survival and influences the development of bipotential granulocyte-macrophage colony-forming cells.
    Kan O; Heyworth CM; Dexter TM; Maudsley PJ; Cook N; Vallance SJ; Whetton AD
    Blood; 1991 Nov; 78(10):2588-94. PubMed ID: 1824254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-macrophage colony-stimulating factor is not involved in production of reactive nitrogen intermediates by or toxoplasmastatic activity of gamma interferon-activated murine macrophages.
    Buisman A; van Dissel JT; Langermans JA; van Furth R
    Infect Immun; 1994 Mar; 62(3):1121-4. PubMed ID: 8112845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
    Denis M
    J Leukoc Biol; 1991 Apr; 49(4):380-7. PubMed ID: 1900522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of recombinant human granulocyte macrophage-colony stimulating factor in long-term marrow cultures from patients with aplastic anemia.
    Martínez-Jaramillo G; Gómez-Morales E; Mayani H
    Am J Hematol; 1999 Jun; 61(2):107-14. PubMed ID: 10367789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
    Mayer P; Werner FJ; Lam C; Besemer J
    Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.
    Weiser WY; Van Niel A; Clark SC; David JR; Remold HG
    J Exp Med; 1987 Nov; 166(5):1436-46. PubMed ID: 3119759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M; Hull G; Metcalfe DD
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC).
    Hofer M; Vacek A; Weiterová L
    Physiol Res; 2005; 54(2):207-13. PubMed ID: 15544422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis.
    Ho JL; Reed SG; Wick EA; Giordano M
    J Infect Dis; 1990 Jul; 162(1):224-30. PubMed ID: 2113077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
    Baltch AL; Bopp LH; Smith RP; Ritz WJ; Carlyn CJ; Michelsen PB
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
    Cairo MS; Mauss D; Kommareddy S; Norris K; van de Ven C; Modanlou H
    Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Chiller T; Farrokhshad K; Brummer E; Stevens DA
    Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro regulation of human phagocyte cytochrome b heavy and light chain gene expression by bacterial lipopolysaccharide and recombinant human cytokines.
    Newburger PE; Dai Q; Whitney C
    J Biol Chem; 1991 Aug; 266(24):16171-7. PubMed ID: 1714908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent cholesterol-lowering effect by human granulocyte-macrophage colony-stimulating factor in rabbits. Possible implications of enhancement of macrophage functions and an increase in mRNA for VLDL receptor.
    Ishibashi T; Yokoyama K; Shindo J; Hamazaki Y; Endo Y; Sato T; Takahashi S; Kawarabayasi Y; Shiomi M; Yamamoto T
    Arterioscler Thromb; 1994 Oct; 14(10):1534-41. PubMed ID: 7918302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony-stimulating factor in patients with lymphoma.
    Kharazmi A; Nielsen H; Hovgaard D; Borregaard N; Nissen NI
    Eur J Clin Invest; 1991 Apr; 21(2):219-24. PubMed ID: 1905635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effects of recombinant human granulocyte-macrophage colony-stimulating factor (RhGM-CSF) on polymorphonuclear cell (PMN) and monocyte (MO) functional capacities in ovarian cancer patients versus human volunteers.
    Altamura M; Geronimo MG; Pepe M; Lella P; Nappi L; Loizzi P; Forte M; Marsilio M; Piazzolla G; Antonaci S; Jirillo E
    Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):437-49. PubMed ID: 9436044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocyte-mediated killing of human leukaemia is enhanced by administration of granulocyte-macrophage colony stimulating factor following chemotherapy.
    Williams MA; Newland AC; Kelsey SM
    Br J Haematol; 1997 Sep; 98(4):960-8. PubMed ID: 9326196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.